Clinical Study of Acupoint Application on Relieving qi Deficiency and Constipation in Pati
4.1 Research Content 1. Clarifying the acupoint application scheme for deficiency and constipation in CRC patients undergoing chemotherapy: the preliminary acupoint application scheme for deficiency and constipation in CRC patients was formulated according to the systematic literature search, analysis of acupoint and t
| Condition(s) | Postoperative Chemotherapy, Chemotherapy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | 4.1 Research Content 1. Clarifying the acupoint application scheme for deficiency and constipation in CRC patients undergoing chemotherapy: the preliminary acupoint application scheme for deficiency and constipation in CRC patients was formulated according to the systematic literature search, analysis of acupoint and traditional Chinese medicine prescription, analysis of meridian tropism of acupoints, Chinese herbal medicine taste and meridian tropism, etc., and multidisciplinary expert consultation. Through two rounds of Delphi expert letter consultation, the acupoint application scheme for deficiency and secret of CRC patients undergoing chemotherapy was determined. 2. Randomized controlled trials were conducted to compare the effect of acupoint application scheme and conventional treatm |
| Who can participate | Inclusion Criteria: 1. Clinical diagnosis of colorectal cancer 2. Chemotherapy was performed after surgery 3. Diagnosis of qi deficiency and constipation 4. Age ≥18 years old Exclusion Criteria: 1. Clinical diagnosis of other digestive tract or anal organic diseases 2. Observed with severe cardiac, hepatic, renal insufficiency or other complications 3. Allergic constitution or allergy to a drug in constipation paste |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Locations | Hangzhou, Zhejiang, China |
| Start date | 2025-07-16 |
| NCT ID | NCT07276932 |
| Official listing | https://clinicaltrials.gov/study/NCT07276932 |